/ /

  • linkedin
  • Increase Font
  • Sharebar

    Puff The Magic Pot Dragon

    Like all ophthalmologists, I budget copious time to read each and every issue of Ophthalmology Times from cover-to-cover.  But lately, I find that reading a daily newspaper is sometimes too much of a luxury, and typically I simply look at the headlines, skim the first few sentences, and move on the next article.  Five minutes max to read the entire newspaper each morning, then out the door to get to my office.

    More in this issue: How to have healthy awareness and educate yourself regarding ACOs

    A recent publication in the Baltimore Sun, however, arrested my attention and demanded that I spend the time to read it carefully.  Entitled, “Doctors Need Marijuana Training,” the article responds to recent legislation passed in my state enabling physicians to prescribe marijuana for medical purposes.

    The ever-so-promising title of this article, penned by the president and interim executive director of the Pharmacists’ Education and Advocacy Council of Maryland, gave me the wrong idea.  Logically, I assumed the article was advocating for requiring physicians to attending workshops conducted by tie-dyed instructors in which giggling attendees listen to Bob Marley CDs while passing around reefers (with big bowls of Cheetos, instead of bagels, at the tables during the breaks in the course). This might be one CME course worth closing down the office!        

    Sadly, this is not the case.

    Insufficient marijuana education

    Peter McDonnell, MD
    He is director of The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, and chief medical editor of ...

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results